7-Ethyl-d3-camptothecin
Product Code
TRC-E900832
CAS Number
Product Format
Neat
Molecular Formula
C22H17D3N2O4
Molecular Weight
379.42
Product Categories
TRC, Additional Cancer Bioactive Molecules, Stable isotopes, Impurity Reference Materials , Stable isotopes, Stable Isotope Labelled Analytical Standards
Product Type
Stable Isotope LabelledUnlabelled CAS Number
Documentation
Looking for another lot?
To view all certificates of analysis immediately, please login to your account
or
{{ errors.first('lotNumber') }}
{{ errors.first('requestEmail') }}
For information about our data processing activities, please visit our Privacy Notice.
Enter your email address and we'll email you the relevant CoA for lots:
{{ coaPopupData.packSize.coaSelectedLotNumbers }}
{{ errors.first('coaEmail') }}
We will be sending the CoA to your email address {{ coaEmailPopupData.userEmail }}
Your request has been sent to our sales team to process.
Find an SDS for your region
{{ errors.first('selectedRegion') }}
{{ errors.first('sdsEmail') }}
For information about our data processing activities, please visit our Privacy Notice.
Your request has been sent to our sales team to process.
Product Information
Chemical Data
Analyte Name
7-Ethyl-d3-camptothecin
CAS Number
1217626-02-2
Molecular Formula
C22H17D3N2O4
Molecular Weight
379.42
Accurate Mass
379.16
SMILES
O=C1C2=C([C@@](O)(CC)C(OC2)=O)C=C3C4=NC5=CC=CC=C5C(CC([2H])([2H])[2H])=C4CN31
InChI
InChI=1S/C22H20N2O4/c1-3-12-13-7-5-6-8-17(13)23-19-14(12)10-24-18(19)9-16-15(20(24)25)11-28-21(26)22(16,27)4-2/h5-9,27H,3-4,10-11H2,1-2H3/t22-/m0/s1/i1D3
IUPAC
(S)-4-ethyl-11-(ethyl-2,2,2-d3)-4-hydroxy-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione
Unlabelled CAS Number
78287-27-1
SIL Type
Deuterium
Product Data
Storage Temperature
+4°C
Shipping Temperature
Room Temperature
Country of Origin
CANADA
Product Type
Stable Isotope Labelled
Product Format
Neat
Product Description
An anticancer drug, showed strong activity against various murine tumors. A Labelled camptothecin(CPT) derivative as antineoplastic agent against drug-resistant tumors.
References: Miyake, K., et al.: Cancer Res., 59, 8 (1999)